Financials

  • Market Capitalization 75.47 M
  • Employee 24
  • Founded 2011
  • CEO N/A
  • Website www.neuraxis.com
  • Headquarter Delaware, United States
  • FIGI BBG01C9N12C3
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.49
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4048
GANX
Gain Therapeutics, Inc. - Common Stock
1.80 USD-1.10%+1.69%+1.12%+1.69%78.56 M USD
4060
RNTX
Rein Therapeutics, Inc. - Common Stock
0.89 USD+5.95%+15.58%+23.61%-19.11%76.78 M USD
4082
CING
Cingulate Inc. - Common Stock
5.10 USD-2.30%-4.32%+3.03%-17.21%74.16 M USD
4083
CALC
CalciMedica, Inc. - Common Stock
2.17 USD-1.36%-5.65%+193.24%-30.23%74.09 M USD

Nouvelles